Position in ALLO
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,932,036
+$1,619,831 QoQ
Shares Held
1,201,655
+25.5% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 76%
Shared 9%
None 15%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ALLO ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ALLO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,932,036 | 1,201,655 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,312,205 | 957,816 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,592,531 | 2,090,753 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,092,151 | 2,736,419 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,642,584 | 3,179,853 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,586,260 | 3,561,626 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,645,342 | 2,730,480 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,942,988 | 2,550,640 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,134,974 | 2,043,619 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,928,135 | 1,535,245 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,827,587 | 1,838,356 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,421,938 | 1,292,141 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,123,321 | 2,049,256 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,033,751 | 2,390,104 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,735,697 | 1,734,787 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $14,303,440 | 1,254,688 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,342,541 | 805,987 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,111,341 | 744,728 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $8,767,683 | 341,155 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $569,691 | 21,844 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $771,093 | 21,844 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,144,709 | 45,353 | Shares | Sole | 2021-03-08 | |
| 2020-09-30 | $1,830,745 | 48,548 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||